NO BENEFIT OF HYPOMETHYLATING AGENTS COMPARED TO SUPPORTIVE CARE FOR HIGHER RISK MYELODYSPLASTIC SYNDROME BY IPSS-R

Lee, Y; Sohn, S; Ahn, J; Kim, HJ; Shin, HJ; Lee, HS; Suh, J; Do, YR; Kim, BS

LEUKEMIA RESEARCH, 2017; 55 ( ): S65